Table 1. Baseline and Demographic Characteristics of Participants.
| Characteristic | Participants, No. (%) | ||
|---|---|---|---|
| All patients (N = 67) | Placebo (N = 34) | Niclosamide (N = 33) | |
| Age, mean (SD), y | 36.39 (13.01) | 35.97 (13.27) | 36.82 (12.92) |
| Sex | |||
| Men | 41 (61.2) | 21 (61.8) | 20 (60.6) |
| Women | 26 (38.8) | 13 (38.2) | 13 (39.4) |
| Race and ethnicity | |||
| African American or Black | 4 (6.0) | 3 (8.8) | 1 (3.0) |
| Asian | 5 (7.5) | 2 (5.9) | 3 (9.1) |
| Hispanic or Latinx | 7 (10.4) | 1 (2.9) | 6 (18.2) |
| White | 53 (79.1) | 27 (79.4) | 26 (78.8) |
| Multiracial or multiethnica | 1 (1.5) | 1 (2.9) | 0 |
| Otherb | 4 (6.0) | 1 (2.9) | 3 (9.1) |
| Smoking status | |||
| Nonsmoker | 51 (76.1) | 27 (79.4) | 24 (72.7) |
| Former smoker | 10 (14.9) | 4 (11.8) | 6 (18.2) |
| Current smoker | 6 (9.0) | 3 (8.8) | 3 (9.1) |
| Medical condition | |||
| Heart condition | 1 (1.5) | 1 (2.9) | 0 |
| Asthma | 5 (7.5) | 4 (11.8) | 1 (3.0) |
| Hypertension | 5 (7.5) | 2 (5.9) | 3 (9.1) |
| BMIc | |||
| Reference range | 26 (45.6) | 13 (46.4) | 13 (44.8) |
| Overweight | 24 (42.1) | 10 (35.7) | 14 (48.3) |
| Obese | 4 (7.0) | 4 (14.3) | 0 |
| Severely obese | 3 (5.3) | 1 (3.6) | 2 (6.9) |
| Mean (SD) | 27.04 (6.73) | 27.25 (7.91) | 26.83 (5.49) |
| Pills used, median (IQR), No. | 28.00 (28.00-28.00) | 28.00 (28.00-28.00) | 28.00 (28.00-28.00) |
Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared).
a
One participant self-reported as Asian and White.
b
The other race and ethnicity category includes individuals with Middle Eastern backgrounds or undisclosed race and ethnicity.
c
BMI categories were reference range (<25), overweight (25 to <30), obese (30 to <35), and severely obese (≥35).